Document Detail


Management of Kaposi's sarcoma in resource-limited settings in the era of HAART.
MedLine Citation:
PMID:  15875657     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
The introduction of highly active antiretroviral therapy (HAART) has changed the natural history of AIDS-associated Kaposi's sarcoma (KS). Although the use of HAART remains limited in low-resource settings, there are global initiatives to make these drugs available to several millions of HIV-infected persons. While there are multiple reports of KS regression during HAART with or without chemotherapy, there is little documentation on KS management in resource-limited settings. In this paper we review current KS treatments available worldwide and discuss the implications of the increased access to antiretrovirals for KS treatment strategies in resource-limited settings.
Authors:
Lut Lynen; Maria Zolfo; Veerle Huyst; Francoise Louis; Pieter Barnardt; Ann Van de Velde; Caroline De Schacht; Robert Colebunders
Related Documents :
8508077 - Primary esophageal lymphoma in aids.
6093247 - Htlv-iii in saliva of people with aids-related complex and healthy homosexual men at ri...
2058637 - Appendiceal kaposi's sarcoma: a cause of right lower quadrant pain in the acquired immu...
6313297 - Pathogenesis of the acquired immune deficiency syndrome (aids).
20422257 - Factors in reliable treatment plant operation for the production of safe water.
15355147 - Having the memory of an elephant: long-term retrieval and the use of analogues in probl...
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  AIDS reviews     Volume:  7     ISSN:  1139-6121     ISO Abbreviation:  AIDS Rev     Publication Date:    2005 Jan-Mar
Date Detail:
Created Date:  2005-05-06     Completed Date:  2005-06-30     Revised Date:  2005-11-16    
Medline Journal Info:
Nlm Unique ID:  101134876     Medline TA:  AIDS Rev     Country:  Spain    
Other Details:
Languages:  eng     Pagination:  13-21     Citation Subset:  IM    
Affiliation:
Clinical Sciences Department, Institute of Tropical Medicine, Antwerp, Belgium. llynen@itg.be
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antiretroviral Therapy, Highly Active*
Developing Countries
HIV Infections / complications*,  drug therapy
Humans
Sarcoma, Kaposi / complications,  drug therapy*

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  GB virus C infection: is there a clinical relevance for patients infected with the human immunodefic...
Next Document:  Does RNA interference have a future as a treatment for HIV-1 induced disease?